Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-12-07, Stock:JNJ, The news for the past five days is as follows:
2021-11-30: NEWS1: U.S. administers 460.7 mln doses of COVID-19 vaccines - CDC.NEWS2: Johnson & Johnson Announces Significant Progress Towards Its Climate Goals - 100% Renewable Electricity for All Sites in the United States, Canada and Europe by 2023.NEWS3: Moderna CEO says vaccines likely less effective against Omicron COVID-19 variant.NEWS4: Omicron: 'Time will tell' as we learn more about transmissibility and risk, doctor explains.NEWS5: 'The market doesn't like an information vacuum, and now we have two,' strategist says.NEWS6: UPDATE 1-Slovenia set to ban Janssen vaccine after woman's death.NEWS7: Slovenia set to ban Janssen vaccine after woman's death.NEWS8: These 3 Stocks Have Underperformed the Market This Year. Is Now the Time to Buy?.NEWS9: ‘We can’t have countries lingering at 10%' COVID-19 vaccination, Columbia professor explains.NEWS10: J&J (JNJ) to Explore Omicron Version of its COVID Vaccine.NEWS11: Stocks fall as investors try to gauge Omicron risk, ongoing supply chain issues.NEWS12: Market strategist: Investors ‘don’t want to overreact’ amid Omicron uncertainty.NEWS13: REFILE-UPDATE 3-S.Africa's Aspen signs deal paving way for J&J COVID vaccine licence.NEWS14: S.Africa's Aspen signs non-binding agreement with J&J for COVID vaccine license.
2021-12-01: NEWS1: Johnson & Johnson (JNJ) Gains As Market Dips: What You Should Know.NEWS2: U.S. administers 462.3 mln doses of COVID-19 vaccines - CDC.NEWS3: The US has its first omicron case—and the patient was fully vaccinated.NEWS4: Jim Cramer: Buying the tech dip is a mistake when these 4 stocks offer ‘easier money’.NEWS5: CDC isn’t changing fully vaccinated definition to include boosters ‘right now’.NEWS6: CDC identifies the first case of Omicron variant in the U.S..NEWS7: Inflation ‘is the biggest risk for markets’ going into 2022: Strategist.NEWS8: The CDC isn’t changing its definition of ‘fully vaccinated’ to include boosters.NEWS9: ‘We still have a lot more work to do,’ former White House vaccinations coordinator says.NEWS10: Omicron variant: The Biden administration plans to tighten restrictions for travelers to the U.S..NEWS11: Moderna's (MRNA) Stock Falls on Omicron Variant Concerns.NEWS12: Omicron: Doctor details key questions about new COVID-19 variant.NEWS13: Medtronic CEO on partnering with Elon Musk at the height of COVID-19.
2021-12-02: NEWS1: U.S. administers 464.4 mln doses of COVID-19 vaccines - CDC.NEWS2: 'Investors need to take a longer term perspective' amid market volatility, strategist says.NEWS3: Biden’s new COVID-19 plan includes ‘two new points,’ analyst explains.NEWS4: President Biden outlines steps to combat COVID-19 in winter.NEWS5: Doctor: U.S. needs to prepare for ‘a potential perfect storm' between Omicron variant and winter.NEWS6: Fauci says changing fully vaccinated definition to include boosters ‘on the table’.NEWS7: Omicron variant: Areas with high vaccination rates ‘will just see this as a ripple, not a surge,’ doctor says.NEWS8: COVID: Second Omicron variant case identified in Minnesota.NEWS9: COVID: The Omicron variant ‘doubles down on the importance’ of booster shots, doctor says.NEWS10: Coronavirus update: Biden administration plans for winter COVID-19 surge.NEWS11: Rimsys closes on $16 million Series A fund led by Silicon Valley's Bessemer Venture Partners.NEWS12: Amgen (AMGN) Kyprolis Gets FDA Nod for Use With Darzalex Faspro.NEWS13: Influencers with Andy Serwer: Geoff Martha.
2021-12-03: NEWS1: The New 'Mutant Virus' Signals A Need For Annual Shots: BioNTech CEO.NEWS2: Doctor explains what we know about the Omicron variant's spread.NEWS3: Novavax (NVAX) Starts Developing Omicron-Specific COVID Jab.NEWS4: A new study finds that most COVID-19 boosters strengthen immunity, though there is no winning shot.NEWS5: The 'Highly Mutated Virus' Signals A Need For Annual Shots: BioNTech CEO.NEWS6: COVID: ‘We need to stop wearing cloth masks and go to N95s for all,’ expert says.NEWS7: COVID-19 Vaccine & Drug Makers Gear Up to Fight Omicron.NEWS8: Why is Africa’s Covid-19 vaccination rate so low?.NEWS9: 10 Dividend Stocks That Have Doubled Their Payouts.NEWS10: Pharma Stock Roundup: FDA Panel Vote for MRK COVID Pill, JNJ Omicron Jab Plan.
2021-12-06: NEWS1: Signature Select Canadian Fund Buys CI Global Financial Sector ETF, Sun Life Financial Inc, ....NEWS2: Where Do Hedge Funds Stand On Johnson & Johnson (JNJ)?.NEWS3: Vaccine Stocks: The Beginning of the End?.NEWS4: COVID testing remains 'troublesome' in various areas of the U.S., doctor explains.NEWS5: Omicron variant: We don’t need to go into panic mode right now, physician says.NEWS6: COVID: NYC expands vaccine mandate to include children.NEWS7: How millions of COVID vaccines are paid for.NEWS8: J&J (JNJ) COVID-19 Booster Jab Compares Well With Comirnaty.NEWS9: In Fashion: Breaking Down the Corporate Breakups.NEWS10: Here's Why I Bought Shiba Inu Coin Instead of Johnson & Johnson Stock.NEWS11: The Zacks Analyst Blog Highlights: Moderna, Pfizer, BioNTech, J&J and Regeneron.

Answer: Rise